Literature DB >> 7653682

Diagnostic accuracy and linkage analysis: how useful are schizophrenia spectrum phenotypes?

S V Faraone1, W S Kremen, M J Lyons, J R Pepple, L J Seidman, M T Tsuang.   

Abstract

OBJECTIVE: Numerous studies suggest that the nonschizophrenic relatives of schizophrenic patients exhibit psychiatric and other features that discriminate them from normal comparison subjects. These features have been put forth as "spectrum" phenotypes that may be variant manifestations of the schizophrenia genotype. However, most of these studies do not address a key measurement question: does the diagnostic accuracy of these spectrum classifications warrant their use in genetic linkage studies of schizophrenia?
METHOD: The authors reviewed 30 studies of putative indicators of the schizophrenic genotype: schizotypal personality disorder, eye tracking dysfunction, attentional impairment, auditory evoked potentials, neurological signs, neuropsychological impairment, and allusive thinking.
RESULTS: Although each of 42 measures of these indicators discriminated the relatives of schizophrenic patients from the normal comparison subjects, a diagnostic accuracy analysis suggested that only six of these would improve the informativeness of genetic linkage data.
CONCLUSIONS: Many proposed spectrum phenotypes for schizophrenia may not be useful for linkage analysis because of high false positive rates (poor specificity). Future work aimed at describing and developing phenotypes for linkage analysis should assess the diagnostic accuracy of proposed measures.

Entities:  

Mesh:

Year:  1995        PMID: 7653682     DOI: 10.1176/ajp.152.9.1286

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  21 in total

1.  The future of psychiatric genetics.

Authors:  M T Tsuang; S V Faraone
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

Review 2.  Schizotaxia: current status and future directions.

Authors:  Ming T Tsuang; William S Stone; Franziska Gamma; Stephen V Faraone
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

Review 3.  The obsessive-compulsive spectrums.

Authors:  Katharine A Phillips
Journal:  Psychiatr Clin North Am       Date:  2002-12

4.  Neurocognitive and clinical dysfunction in adult Chinese, nonpsychotic relatives of patients with schizophrenia: Findings from the Changsha study and evidence for schizotaxia.

Authors:  William S Stone; Xiaolu Hsi; Liwen Tan; Shaochun Zhu; Lingjiang Li; Anthony J Giuliano; Larry J Seidman; Ming T Tsuang
Journal:  Asian J Psychiatr       Date:  2012-03

Review 5.  Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes.

Authors:  Beth E Snitz; Angus W Macdonald; Cameron S Carter
Journal:  Schizophr Bull       Date:  2005-09-15       Impact factor: 9.306

6.  Fragile early visual percepts mark genetic liability specific to schizophrenia.

Authors:  Scott R Sponheim; Sarah M Sass; Althea L Noukki; Bridget M Hegeman
Journal:  Schizophr Bull       Date:  2012-03-23       Impact factor: 9.306

7.  Data gathering: biased in psychosis?

Authors:  Frank Van Dael; Dagmar Versmissen; Ilse Janssen; Inez Myin-Germeys; Jim van Os; Lydia Krabbendam
Journal:  Schizophr Bull       Date:  2005-10-27       Impact factor: 9.306

Review 8.  Defining the schizophrenia phenotype.

Authors:  G K Thaker
Journal:  Curr Psychiatry Rep       Date:  2000-10       Impact factor: 5.285

9.  Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p.

Authors:  L M Brzustowicz; W G Honer; E W Chow; J Hogan; K Hodgkinson; A S Bassett
Journal:  Am J Hum Genet       Date:  1997-12       Impact factor: 11.025

10.  Familial transmission of derived phenotypes for molecular genetic studies of substance use disorders.

Authors:  Stephen V Faraone; Joel J Adamson; Timothy E Wilens; Michael C Monuteaux; Joseph Biederman
Journal:  Drug Alcohol Depend       Date:  2007-09-04       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.